- Home
- PEV vs CMMB Comparison
PEV vs CMMB Comparison
Compare PEV & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEV
- CMMB
- Stock Information
- Founded
- PEV 2002
- CMMB 2004
- Country
- PEV United States
- CMMB Israel
- Employees
- PEV N/A
- CMMB N/A
- Industry
- PEV Auto Manufacturing
- CMMB Biotechnology: Pharmaceutical Preparations
- Sector
- PEV Consumer Discretionary
- CMMB Health Care
- Exchange
- PEV Nasdaq
- CMMB Nasdaq
- Market Cap
- PEV 15.8M
- CMMB 15.8M
- IPO Year
- PEV 2022
- CMMB N/A
- Fundamental
- Price
- PEV $0.70
- CMMB $1.34
- Analyst Decision
- PEV
- CMMB Strong Buy
- Analyst Count
- PEV 0
- CMMB 3
- Target Price
- PEV N/A
- CMMB $5.67
- AVG Volume (30 Days)
- PEV 14.4M
- CMMB 209.5K
- Earning Date
- PEV 11-12-2024
- CMMB 11-07-2024
- Dividend Yield
- PEV N/A
- CMMB N/A
- EPS Growth
- PEV N/A
- CMMB N/A
- EPS
- PEV N/A
- CMMB N/A
- Revenue
- PEV $10,761,000.00
- CMMB N/A
- Revenue This Year
- PEV N/A
- CMMB N/A
- Revenue Next Year
- PEV N/A
- CMMB N/A
- P/E Ratio
- PEV N/A
- CMMB N/A
- Revenue Growth
- PEV 97.81
- CMMB N/A
- 52 Week Low
- PEV $0.32
- CMMB $0.42
- 52 Week High
- PEV $1.79
- CMMB $2.55
- Technical
- Relative Strength Index (RSI)
- PEV 58.32
- CMMB 36.04
- Support Level
- PEV $0.70
- CMMB $1.31
- Resistance Level
- PEV $1.39
- CMMB $1.59
- Average True Range (ATR)
- PEV 0.12
- CMMB 0.16
- MACD
- PEV 0.05
- CMMB -0.04
- Stochastic Oscillator
- PEV 34.94
- CMMB 12.24
About PEV Phoenix Motor Inc.
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.